Clinical

Dataset Information

0

Is it safe to add cediranib to weekly paclitaxel chemotherapy in women with ovarian cancer who are at risk of developing malignant bowel obstruction?


ABSTRACT: See https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-of-cediranib-for-women-with-ovarian-cancer-at-risk-of-having-a-bowel-obstruction-ceboc

DISEASE(S): Progressive,Platinum-resistant Ovarian Cancer,Platinum-resistant Or Refractory,High-grade Ovarian,Ovarian Cancer Recurrent,Neoplasms Benign, Malignant And Unspecified (incl Cysts And Polyps),Fallopian Tube Or Primary Peritoneal Cancer With High Risk Of Bowel Obstruction.

PROVIDER: 2416782 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2013-07-01 | GSE32569 | GEO
| S-EPMC6457624 | biostudies-literature
2014-05-05 | E-MTAB-2126 | biostudies-arrayexpress
2013-09-09 | E-MTAB-1627 | biostudies-arrayexpress
| S-EPMC5081077 | biostudies-literature
2013-07-01 | E-GEOD-32569 | biostudies-arrayexpress
| 2419299 | ecrin-mdr-crc
| PRJEB1858 | ENA
| S-EPMC5665762 | biostudies-literature
| S-EPMC3899763 | biostudies-literature